Clover Health Investments, Corp. (CLOV)
| Market Cap | 1.44B |
| Revenue (ttm) | 1.77B |
| Net Income (ttm) | -58.32M |
| Shares Out | 514.19M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | 81.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,354,048 |
| Open | 2.820 |
| Previous Close | 3.520 |
| Day's Range | 2.590 - 2.850 |
| 52-Week Range | 2.120 - 4.870 |
| Beta | 2.23 |
| Analysts | Strong Buy |
| Price Target | 4.37 (+56.35%) |
| Earnings Date | Nov 4, 2025 |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware. [Read more]
Financial Performance
In 2024, Clover Health Investments's revenue was $1.37 billion, an increase of 8.52% compared to the previous year's $1.26 billion. Losses were -$43.01 million, -79.84% less than in 2023.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for CLOV stock is "Strong Buy." The 12-month stock price target is $4.37, which is an increase of 56.35% from the latest price.
News
Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript
Clover Health Investments, Corp. ( CLOV) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Pete...
Clover Health Reports Third Quarter 2025 Results
Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greate...
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-servi...
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care t...
Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade
Clover's latest star rating downgrade was mainly driven by low member experience scores, which is an aspect it fully controls in its business. Despite low member experience scores, members' ratings fo...
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portf...
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent ...
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing a...
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf...
Counterpart Assistant Gets Conversational
SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or t...
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades Dr. Duncan's appointment to this p...
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlinin...
Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
The latest AI-powered feature in Counterpart Assistant streamlines documentation, enhances physician workflows, and raises the bar for value-based care across practice settings at no additional cost t...
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had the honor to ...
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential
While Clover Health's Q2 earnings showed continued member and revenue growth, it dropped 30% since then due to higher medical costs that impacted all MA plan providers. Clover Health still maintains i...
Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call Transcript
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Andrew Toy - Co-Founder, CEO & Director Peter J. Kuipers - Chief Financi...
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth
Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-year Second quarter 2025 Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics ...
Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis,...
Clover Health Applauds White House and CMS' Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians
WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on...
Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution
WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or...
Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller
WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on...
Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC's iCare+ Network
WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, ...